honeycomb shape

Topline Results from the ALPINE 2/3 Study: a Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2b Trial Evaluating 3 Doses of the FGF19 Analogue Aldafermin on Liver Histology in Patients with Nonalcoholic Steatohepatitis and Stage 2 and 3 Fibrosis

November 15th 2021

Listen to oral presentation
Download PDF of presentation